Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31383969 | 1.00 | ALDH1A1 (0.34) | ALDH1A1 | |
| SCHEMBL23980631 | 0.82 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL21518258 | 0.78 | HTR5A (0.35) | ALDH1A1 | |
| SCHEMBL2963160 | 0.76 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL27744863 | 0.75 | CYP2D6 (0.36) | ALDH1A1 | |
| SCHEMBL2974954 | 0.75 | — | — | |
| SCHEMBL2957365 | 0.75 | — | — | |
| SCHEMBL2964337 | 0.75 | HTR2A (0.30) | — | |
| SCHEMBL2970449 | 0.75 | GABRA1 (0.33) | — | |
| SCHEMBL2964220 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025064802-A1 | INHIBITING HUMAN INTEGRIN α5β1 | MORPHIC THERAPEUTIC, INC. (US) | 2025-03-27 | — | — | WO | disclosed |
| CN-108779135-B | Metallocene compound, catalyst component and catalyst for olefin polymerization comprising the same, and process for producing olefin polymer using the same | 日本聚乙烯株式会社 | 2021-09-07 | — | — | CN | disclosed |
| US-10995167-B2 | Metallocene compound, catalyst component for olefin polymerization and catalyst for olefin polymerization containing the same, and method for producing olefin polymer using catalyst for olefin polymerization | JAPAN POLYETHYLENE CORPORATION (JP) | 2021-05-04 | — | — | US | disclosed |
| EP-3431483-B1 | METALLOCENE COMPOUND, CATALYST COMPONENT FOR OLEFIN POLYMERIZATION AND CATALYST FOR OLEFIN POLYMERIZATION CONTAINING THE SAME, AND METHOD FOR PRODUCING OLEFIN POLYMER USING CATALYST FOR OLEFIN POLYMERIZATION CATALYST | JAPAN POLYETHYLENE CORP (JP) | 2021-03-03 | — | — | EP | disclosed |
| US-20190092887-A1 | METALLOCENE COMPOUND, CATALYST COMPONENT FOR OLEFIN POLYMERIZATION AND CATALYST FOR OLEFIN POLYMERIZATION CONTAINING THE SAME, AND METHOD FOR PRODUCING OLEFIN POLYMER USING CATALYST FOR OLEFIN POLYMERIZATION | JAPAN POLYETHYLENE CORPORATION (JP) | 2019-03-28 | — | — | US | disclosed |
| EP-3431483-A1 | METALLOCENE COMPOUND, OLEFIN POLYMERIZATION CATALYST COMPONENT AND OLEFIN POLYMERIZATION CATALYST EACH COMPRISING SAME, AND METHOD FOR PRODUCING OLEFIN POLYMER USING SAID OLEFIN POLYMERIZATION CATALYST | Japan Polyethylene Corporation (JP) | 2019-01-23 | — | — | EP | disclosed |
| CN-108779135-A | Metallocene compound, the catalyst component for olefin comprising it and catalyst for olefines polymerizing and the method for producing olefin polymer using catalyst for olefines polymerizing | 日本聚乙烯株式会社 | 2018-11-09 | — | — | CN | disclosed |
| US-20140319507-A1 | Organic Electroluminescent Element, Material for Organic Electroluminescent Element, Light Emitting Device, Display Device and Lighting Device Each Using Said Element, and Compound Used for Said Element | UDC IRELAND LIMITED (IE) | 2014-10-30 | — | — | US | disclosed |
| US-7763562-B2 | Heteroatom bridged metallocene compounds for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2010-07-27 | — | — | US | disclosed |
| US-20070135597-A1 | Heteroatom bridged metallocene compounds for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2007-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190092887-A1 | METALLOCENE COMPOUND, CATALYST COMPONENT FOR OLEFIN POLYMERIZATION AND CATALYST FOR OLEFIN POLYMERIZATION CONTAINING THE SAME, AND METHOD FOR PRODUCING OLEFIN POLYMER USING CATALYST FOR OLEFIN POLYMERIZATION | COG1, CPNE4, COG4 | ALDH1A1 413/4885 |
| US-20070135597-A1 | Heteroatom bridged metallocene compounds for olefin polymerization | AP2M1, AP1M1, PYM1 | ALDH1A1 4332/4885 |
| US-10995167-B2 | Metallocene compound, catalyst component for olefin polymerization and catalyst for olefin polymerization containing the same, and method for producing olefin polymer using catalyst for olefin polymerization | COG1, CPNE4, COG4 | ALDH1A1 413/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.